Search results
Showing 706 to 720 of 8939 results
All NICE products on heart rhythm conditions. Includes any guidance, advice and quality standards.
All NICE products on peripheral circulatory conditions. Includes any guidance, advice and quality standards.
All NICE products on older people. Includes any guidance, advice and quality standards.
All NICE products on people with learning disabilities. Includes any guidance and quality standards.
All NICE products on people with physical disabilities. Includes any guidance.
This webpage covers all NICE's guidelines on mental health. The table presents the guidelines alphabetically. Updates planned or in progress are...
All NICE products on cholelithiasis and cholecystitis. Includes any guidance and quality standards.
All NICE products on vulnerable groups. Includes any guidance and quality standards.
All NICE products on constipation. Includes any guidance and quality standards.
All NICE products on embolism and thrombosis. Includes any guidance, advice and quality standards.
All NICE products on heart failure. Includes any guidance, advice and quality standards.
All NICE products on coeliac disease. Includes any guidance and quality standards.
All NICE products on blood conditions. Includes any guidance, advice and quality standards.
All NICE products on blood and bone marrow cancers. Includes any guidance, advice and quality standards.
This quality standard covers prevention of type 2 diabetes in adults (aged 18 and over) and care and treatment for adults with type 2 diabetes. It describes high-quality care in priority areas for improvement.
View quality statements for QS209Show all sections
Sections for QS209
- Quality statements
- Quality statement 1: Preventing type 2 diabetes
- Quality statement 2: Structured education programme
- Quality statement 3: Continuous glucose monitoring for adults on multiple daily insulin injections who cannot self-monitor using capillary blood glucose monitoring
- Quality statement 4: Continuous glucose monitoring for adults who use insulin and need help monitoring their blood glucose
- Quality statement 5: Treatment with an SGLT-2 inhibitor
- Quality statement 6: 9 key care processes
- Quality statement 7: Assessing the risk of diabetic foot problems on admission to hospital